Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SELECT MEDICAL HOLDINGS CORP Director's Dealing 2021

Mar 5, 2021

31892_dirs_2021-03-04_05db13d0-3245-4278-bf64-aa5c02baae69.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SELECT MEDICAL HOLDINGS CORP (SEM)
CIK: 0001320414
Period of Report: 2021-03-03

Reporting Person: ORTENZIO ROBERT A (Director, Exec. Chairman and Co-Founder)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-03-03 Common Stock S 15898 $34.00 Disposed 5140982 Direct
2021-03-03 Common Stock S 10598 $34.00 Disposed 1638402 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1445195 Indirect
Common Stock 3804805 Indirect
Common Stock 497156 Indirect
Common Stock 800000 Indirect
Common Stock 56669 Indirect
Common Stock 54553 Indirect
Common Stock 54553 Indirect
Common Stock 54552 Indirect

Footnotes

F1: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on March 13, 2020.

F2: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Robert A. Ortenzio Descendants Trust on March 13, 2020.

F3: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.